Please login to the form below

Not currently logged in
Email:
Password:

Consilium Strategic Communications wins Vectura account

Will advise on financial and corporate PR following SkyePharma merger

Consilium Strategic CommunicationsConsilium Strategic Communications has been selected by Vectura to advise on its international financial and corporate PR dealings, following the completion of its £441m merger with SkyePharma.

The London-based healthcare strategic communications will work with Vectura as it implements its business plan to become an industry-leading respiratory specialist, under the purview of former AstraZeneca executive James Ward-Lilley.

Consilium's Mary-Jane Elliott, Susan Stuart, Jessica Hodgson, Chris Welsh and Melissa Gardiner will have central roles in directing Vectura's PR strategy.

Commenting on the partnership, co-founder managing partner of Consilium Elliot said: “We are delighted to be working with Vectura during such an exciting time for the company and since its merger with Skyepharma.

“Vectura aims to establish its position as the new UK-based international inhaled airways disease-focused powerhouse and we look forward to helping them build the new Vectura story.”

Article by
Rebecca Clifford

23rd September 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics